Taysha Gene Therapies Inc (NASDAQ: TSHA): Stock That Needs Special Handling
Currently, there are 204.94M common shares owned by the public and among those 153.61M shares have been available to trade. The company’s stock has a 5-day price change of -3.45% and 8.62% over the past three months. TSHA shares are trading 42.37% year to date (YTD), with the 12-month market performance up to 40.78% higher. […]
Taysha Gene Therapies Inc (TSHA): Street Finally Waking Up
Currently, there are 204.94M common shares owned by the public and among those 153.61M shares have been available to trade. The company’s stock has a 5-day price change of 24.70% and 49.51% over the past three months. TSHA shares are trading 74.01% year to date (YTD), with the 12-month market performance up to 75.00% higher. […]
Do Taysha Gene Therapies Inc (NASDAQ: TSHA) Fit In A Value Investing Philosophy?
Currently, there are 186.96M common shares owned by the public and among those 153.61M shares have been available to trade. The company’s stock has a 5-day price change of 26.75% and 35.05% over the past three months. TSHA shares are trading 63.28% year to date (YTD), with the 12-month market performance up to 52.91% higher. […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) Loses -50.93% From High. Why That Could Change?
Currently, there are 186.96M common shares owned by the public and among those 153.61M shares have been available to trade. The company’s stock has a 5-day price change of -11.30% and -6.19% over the past three months. TSHA shares are trading 19.77% year to date (YTD), with the 12-month market performance up to 24.71% higher. […]
Growing Through Challenges? – Taysha Gene Therapies Inc (TSHA)
Currently, there are 186.96M common shares owned by the public and among those 158.49M shares have been available to trade. The company’s stock has a 5-day price change of 88.19% and 3.46% over the past three months. TSHA shares are trading 35.03% year to date (YTD), with the 12-month market performance up to 58.80% higher. […]
Taysha Gene Therapies Inc (TSHA): Street Finally Waking Up
Currently, there are 186.96M common shares owned by the public and among those 158.49M shares have been available to trade. The company’s stock has a 5-day price change of -31.98% and -37.67% over the past three months. TSHA shares are trading -24.29% year to date (YTD), with the 12-month market performance down to -44.17% lower. […]
Some Investing Thoughts On Taysha Gene Therapies Inc (NASDAQ: TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on Thursday at a closing price of $2.02, with 2.18 million shares of worth about $4.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -24.63% during that period and on October 03, 2024 the price saw […]
Growth Story Still Intact For Taysha Gene Therapies Inc (TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on Thursday at a closing price of $2.10, with 3.29 million shares of worth about $6.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.75% during that period and on September 26, 2024 the price saw […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) – Not A Clear Buying Opportunity?
Taysha Gene Therapies Inc (TSHA) concluded trading on Wednesday at a closing price of $2.52, with 6.5 million shares of worth about $16.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.25% during that period and on Wednesday the price saw a gain […]
Is Taysha Gene Therapies Inc (NASDAQ: TSHA) Back In The Buying Zone?
Fidelity Management & Research Co recently announced the acquisition of new stake in Taysha Gene Therapies Inc (NASDAQ:TSHA). The institutional investor has increased its shareholding in the Healthcare company by 2,035.03% to 24.53 million shares with purchase of 23.38 million shares. This fresh investment now brings its stake to 13.12% valued currently at $43.17 million. […]
